News | August 04, 2023
Piramal Pharma posts Q1 FY24 consolidated loss at Rs. 98.58 Cr
The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1248.51 crores during the period ended June 30, 2023
The company has reported total income of Rs. 164.63 crores during the period ended June 30, 2023
The company has reported total income of Rs. 6738.4 crores during the period ended June 30, 2023
Astec LifeSciences has reported total income of Rs. 144.55 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
Dr. Lal Path Labs Ltd. has reported total income of Rs. 555.4 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1052.79 crores during the period ended June 30, 2023
Cipla has reported total income of Rs. 6465.18 crores during the period ended June 30, 2023
Jubilant Ingrevia has reported total income of Rs. 1083.52 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
